Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Risk Factors and Prognostic Model for II-IV aGVHD in Patients with Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation

Song Wang, Yan Zhu, Xiaolu Zhu, Haixia Fu, Yun He, Fengrong Wang, Yuanyuan Zhang, Xiaodong Mo, Chenhua Yan, Yuhong Chen, Xiangyu Zhao, Yingjun Chang, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2154.

https://doi.org/10.1182/blood-2023-184380

Published: 2023

Journal Articles

Mega-Dose Decitabine Intensified Regimen Is More Effective at Eliminating Pre-HSCT Measurable Residual Disease Compared to the Bu/Cy Regimen: A Multicenter Prospective Phase II Study

Hao Zheng, Meng Lv, Chenhua Yan, Jing Liu, Yuanyuan Zhang, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiao-Jun Huang

Blood (2023) 142 (Supplement 1): 471.

https://doi.org/10.1182/blood-2023-188932

Published: 2023

Journal Articles

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Blood (2022) 140 (Supplement 1): 5567–5568.

https://doi.org/10.1182/blood-2022-167362

Published: 2022

Journal Articles

Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Blood (2022) 140 (Supplement 1): 2392.

https://doi.org/10.1182/blood-2022-158688

Published: 2022

Journal Articles

Efficacy and Safety of MSCs Plus Basiliximab for the Treatment of Steroid-Resistant aGVHD after Haploidentical Stem Cell Transplantation: A Multicenter, Randomized, Open-Label Trial

Blood (2022) 140 (Supplement 1): 4770–4771.

https://doi.org/10.1182/blood-2022-166307

Published: 2022

Journal Articles

Thrombopoietin Levels Predict the Response to Avatrombopag Treatment in Patients with Persistent Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplantation

Haixia Fu, Meng Lv, Yuanyuan Zhang, Tingting Han, Xiao-Dong Mo, Fengrong Wang, Chenhua Yan, Jun Kong, Yu Wang, Yuqian Sun, Wei Han, Huan Chen, Yao Chen, Yu-Hong Chen, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang

Blood (2022) 140 (Supplement 1): 4705–4706.

https://doi.org/10.1182/blood-2022-166920

Published: 2022

Journal Articles

Superiority of Leukemic Stem Cell-Based Minimal Residual Disease Assay to Traditional Multiparameter Flow Cytometry-Based Method for Relapse Prediction in AML Patients: A Prospective Study with Randomized Training and Validation Sets

Siqi Li, Lan-Ping Xu, Yu Wang, Xiaohui Zhang, Huan Chen, Yu-Hong Chen, Fengrong Wang, Wei Han, Yuqian Sun, Chenhua Yan, Meng Lyu, Feifei Tang, Xiao-Dong Mo, Kai-Yan Liu, Yingjun Chang, Xiao Jun Huang

Blood (2021) 138 (Supplement 1): 517.

https://doi.org/10.1182/blood-2021-150011

Published: 2021

Journal Articles

Prevalence and Risk Factors of Antibodies to Class I and II Human Leukocyte Antigens in Haploidentical Allograft Candidates: A Prospective Study on 3805 Subjects

Ning Ma, Lan-Ping Xu, Xiaohui Zhang, Yu Wang, Huan Chen, Wei Han, Yuqian Sun, Chenhua Yan, Fei-Fei Tang, Xiaodong Mo, Yan-Rong Liu, Kaiyan Liu, Xiao Jun Huang, Ying-Jun Chang

Blood (2021) 138 (Supplement 1): 2880.

https://doi.org/10.1182/blood-2021-149088

Published: 2021

Journal Articles

The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

Gao Mengge, Yan Hong, Zhao Xiangyu, Yuqian Sun, Jun Kong, Zhidong Wang, Fengrong Wang, Jingzhi Wang, Chenhua Yan, Yu Wang, Xiaojun Huang, Xiaosu Zhao

Blood (2021) 138 (Supplement 1): 1686.

https://doi.org/10.1182/blood-2021-146285

Published: 2021

Journal Articles

Mutations Based on Next-Generation Sequencing May be Complementally to Prognostic Risk in Myelodysplastic Syndromes

Jing Wang, MD, Jinsong Jia, Xiaohong Liu, Lizhong Gong, Shengye Lu, Yu Wang, Lanping Xu, Xiaohui Zhang, Chenhua Yan, Yueyun Lai, Xiaosu Zhao, PhD, Yazhen Qin, Guorui Ruan, Yingjun Chang, Hongxia Shi, Kaiyan Liu, Xiaojun Huang, Hao Jiang, MD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-140977

Published: 2020

Journal Articles

The Prognostic Significance of Wilms' Tumor Gene 1 in Adult AML with Different Risk Stratification Following Allo-HSCT

Ke Wang, Songhai Zhou, Yuqian Sun, MD, Chenhua Yan, Yu Wang, Xiaojun Huang, MD, Xiaosu Zhao, PhD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-139026

Published: 2020

Journal Articles

Rituximab for Desensitization during HLA-Mismatched Stem Cell Transplantation in Patients with a Positive Donor Specific Anti-HLA Antibody: A Prospective Study

Ying-Jun Chang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chenhua Yan, Fei-Fei Tang, Ming-Rui Huo, Xiao-Dong Mo, MD, Xiang-Yu Zhao, Kai-yan Liu, Xiao-Jun Huang

Blood (2019) 134 (Supplement_1): 5622.

https://doi.org/10.1182/blood-2019-129781

Published: 2019

Journal Articles

Interferon-a-2b As a Maintenance Therapy Significantly Improves Disease-Free Survival in Patients with Low-Risk Acute Myeloid Leukemia

Xiaohong Liu, Wenbing Duan, Jing Wang, MD, Jinsong Jia, Lizhong Gong, Shen-ye Lu, MD, Xiaosu Zhao, PhD, Ying-Jun Chang, Yue-Yun Lai, Hongxia Shi, Yu Wang, Chenhua Yan, Xiaojun Huang, MD, Hao Jiang

Blood (2019) 134 (Supplement_1): 3823.

https://doi.org/10.1182/blood-2019-128505

Published: 2019

Journal Articles

The Low Number of Mucosal-Associated Invariant T Cells in the Graft Was Associated with Occurrence of Gut Graft-Versus-Host Disease

Gao Mengge, Yan Hong, Yuqian Sun, MD, Jun Kong, MD, Chenhua Yan, PhD, Zhidong Wang, PhD, Yu Wang, Xiaojun Huang, MD, Xiaosu Zhao, PhD

Blood (2019) 134 (Supplement_1): 2001.

https://doi.org/10.1182/blood-2019-127722

Published: 2019

Journal Articles

Observation on the Efficacy of Consolidation Chemotherapy Combined with Allogeneic Natural Killer Cell Infusion in the Treatment of Low and Moderate Risk AML

Hao Jiang, Xiaojun Huang, Chunjian Wang, Lizhong Gong, Jinsong Jia, Xiaohong Liu, Yu Wang, Chenhua Yan, Yingjun Chang, Xiaosu Zhao, PhD, Hongxia Shi

Blood (2019) 134 (Supplement_1): 1378.

https://doi.org/10.1182/blood-2019-122875

Published: 2019

Journal Articles

Disease Risk Comorbidity Index for Patients Receiving Haploidentical Allogeneic Hematopoietic Transplantation

Xiaodong Mo, Xiaohui Zhang, MD, Lanping Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Sining Liu, Kaiyan Liu, Xiaojun Huang

Blood (2019) 134 (Supplement_1): 5716.

https://doi.org/10.1182/blood-2019-124371

Published: 2019

Journal Articles

Risk Factors and Different Therapeutic Patterns of Late-Onset Hemorrhagic Cystitis after Haploidentical Allogeneic Stem Cell Transplantation

Blood (2019) 134 (Supplement_1): 3261.

https://doi.org/10.1182/blood-2019-126230

Published: 2019

Journal Articles

The Efficacy of CT-Diagnostic-Driven Antifungal Strategy with Voriconazole for Invasive Aspergillosis in Patients with Hematological Diseases: A Multicenter, Prospective Study

Yu Ji, Yuqian Sun, Chenhua Yan, Xiaojun Huang, Daihong Liu, Qifa Liu

Blood (2016) 128 (22): 2370.

https://doi.org/10.1182/blood.V128.22.2370.2370

Published: 2016

Journal Articles

Low Dose of Interleukin-2 Therapy Could Prevent Chronic Graft-Versus-Host Disease: A Randomized Study

Xiangyu Zhao, MD PhD, Xiaosu Zhao, Yutong Wang, Xin Qian, Yingjun Chang, Lanping Xu, Xiaohui Zhang, Chen Yuhong, Yu Wang, Wei Han, MD, Huan Chen, Chenhua Yan, Fengrong Wang, Wang Jingzhi, Yao Chen, Yuqian Sun, Kaiyan Liu, Xiaojun Huang

Blood (2014) 124 (21): 39.

https://doi.org/10.1182/blood.V124.21.39.39

Published: 2014

Journal Articles

A Clinical Study On Rituximab for Probable and Proven EBV Disease Post Haematopoietic Stem-Cell Transplantation

Lanping Xu, Daihong Liu, Kaiyan Liu, MD, Chunli Zhang, Fengrong Wang, Jingzhi Wang, Yu Wang, MD, Huan Chen, Yuanyuan Zhang, Chenhua Yan, Wei Han, MD, Yuhong Chen, MD, PhD, Ting Zhao, Xiao-Hui Zhang, Xiaojun Huang

Blood (2012) 120 (21): 4512.

https://doi.org/10.1182/blood.V120.21.4512.4512

Published: 2012

NARROW

Risk Factors and Prognostic Model for II-IV aGVHD in Patients with Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation

Mega-Dose Decitabine Intensified Regimen Is More Effective at Eliminating Pre-HSCT Measurable Residual Disease Compared to the Bu/Cy Regimen: A Multicenter Prospective Phase II Study

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Efficacy and Safety of MSCs Plus Basiliximab for the Treatment of Steroid-Resistant aGVHD after Haploidentical Stem Cell Transplantation: A Multicenter, Randomized, Open-Label Trial

Thrombopoietin Levels Predict the Response to Avatrombopag Treatment in Patients with Persistent Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplantation

Superiority of Leukemic Stem Cell-Based Minimal Residual Disease Assay to Traditional Multiparameter Flow Cytometry-Based Method for Relapse Prediction in AML Patients: A Prospective Study with Randomized Training and Validation Sets

Prevalence and Risk Factors of Antibodies to Class I and II Human Leukocyte Antigens in Haploidentical Allograft Candidates: A Prospective Study on 3805 Subjects

The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

Mutations Based on Next-Generation Sequencing May be Complementally to Prognostic Risk in Myelodysplastic Syndromes

The Prognostic Significance of Wilms' Tumor Gene 1 in Adult AML with Different Risk Stratification Following Allo-HSCT

Rituximab for Desensitization during HLA-Mismatched Stem Cell Transplantation in Patients with a Positive Donor Specific Anti-HLA Antibody: A Prospective Study

Interferon-a-2b As a Maintenance Therapy Significantly Improves Disease-Free Survival in Patients with Low-Risk Acute Myeloid Leukemia

The Low Number of Mucosal-Associated Invariant T Cells in the Graft Was Associated with Occurrence of Gut Graft-Versus-Host Disease

Observation on the Efficacy of Consolidation Chemotherapy Combined with Allogeneic Natural Killer Cell Infusion in the Treatment of Low and Moderate Risk AML

Disease Risk Comorbidity Index for Patients Receiving Haploidentical Allogeneic Hematopoietic Transplantation

Risk Factors and Different Therapeutic Patterns of Late-Onset Hemorrhagic Cystitis after Haploidentical Allogeneic Stem Cell Transplantation

The Efficacy of CT-Diagnostic-Driven Antifungal Strategy with Voriconazole for Invasive Aspergillosis in Patients with Hematological Diseases: A Multicenter, Prospective Study

Low Dose of Interleukin-2 Therapy Could Prevent Chronic Graft-Versus-Host Disease: A Randomized Study

A Clinical Study On Rituximab for Probable and Proven EBV Disease Post Haematopoietic Stem-Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only